Skip to content
Titan Spine logo — Creating Advanced Interbody Fusion Solutions for Cervical an...

Titan Spine

Creating Advanced Interbody Fusion Solutions for Cervical and Lumbar Spine Procedures

Founded 2006 Series B Total: $50.56M Biotechnology, Health Care +2

General Information

Company Name Titan Spine
Founded Year 2006
Industries Biotechnology, Health Care, Manufacturing +1
Funding Stage Series B
Social

BounceWatch is an independent company data service, not affiliated with Titan Spine. To contact Titan Spine, visit titanspine.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Titan Spine compare?

A PDF of Titan Spine and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Titan Spine soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Titan Spine

Titan Spine is a biotechnology and medical devices startup that specializes in producing advanced interbody fusion solutions for cervical and lumbar spine procedures. Their product line includes various devices targeting specific spine regions. The company serves patients in the United States and Europe through its dedicated sales force and a network of independent distributors. Established in 2006 by Kevin Gemas and Peter Ullrich, Titan Spine is headquartered in Mequon, Wisconsin, with operations in Laichingen, Germany. The startup recently received a $16.72M Series B investment on 20 November 2018 from Southlake Equity Group. This strategic alliance is a testament to the potential and growth opportunities for Titan Spine in the biotechnology and medical devices industries.

Business keywords: spinal fusion, orthopedic surgery, interbody fusion, spine surgery, surgical implants, innovative medical solutions

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Series B $16.72M 1
Southlake Equity Group
20 Nov 2018
Series B $15.00M 1
Southlake Equity Group
08 Jan 2018
Series B $1.82M -
09 Jan 2017
Venture Round $9.14M 1
Southlake Equity Group
01 Jan 2017
Venture Round $7.88M 1
Southlake Equity Group
13 Jul 2016

Titan Spine Alternatives & Competitors

View All Alternatives
Titan Spine vs
Accelus
Accelus United States

Accelerating Minimally Invasive Spine Surgery

Debt Financing
81 employees
Health Care, Medical Devices
Titan Spine vs
Cerapedics Inc.
Cerapedics Inc. United States

Cerapedics is a global orthopedics company dedicated to redefining the path to bone repair.

192 employees
Biotechnology, Health Care
Titan Spine vs

Developing innovative modular spinal fusion solutions to enhance surgical treatment of degenerative...

Venture round
1 employees
Biotechnology, Health Care

FAQ About Titan Spine

Creating Advanced Interbody Fusion Solutions for Cervical and Lumbar Spine Procedures
Titan Spine was founded in 2006.
Titan Spine operates in Biotechnology, Health Care, Manufacturing and Medical Devices. Its work centres on spinal fusion, orthopedic surgery, interbody fusion and spine surgery.
Titan Spine has completed 5 funding rounds, raising a total of $50.56M. The latest funding stage is Series B.
Top alternatives and competitors to Titan Spine include Accelus, Cerapedics Inc., RSB SPINE, VTI (Vertebral Technologies, Inc.), Eminent Spine. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Titan Spine and Accelus are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Titan Spine, https://bouncewatch.com/company/titan-spine, updated 27 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout